Literature DB >> 10753910

Rho GTPase control of protein kinase C-related protein kinase activation by 3-phosphoinositide-dependent protein kinase.

P Flynn1, H Mellor, A Casamassima, P J Parker.   

Abstract

The protein kinase C-related protein kinases (PRKs) have been shown to be under the control of the Rho GTPases and influenced by autophosphorylation. In analyzing the relationship between these inputs, it is shown that activation in vitro and in vivo involves the activation loop phosphorylation of PRK1/2 by 3-phosphoinositide-dependent protein kinase-1 (PDK1). Rho overexpression in cultured cells is shown to increase the activation loop phosphorylation of endogenous PRKs and is demonstrated to influence this process by controlling the ability of PRKs to bind to PDK1. The interaction of PRK1/2 with PDK1 is shown to be dependent upon Rho. Direct demonstration of ternary (Rho.PRK.PDK1) complex formation in situ is provided by the observation that PDK1 is recruited to RhoB-containing endosomes only if PRK is coexpressed. Furthermore, this in vivo complex is maintained after phosphoinositide 3-kinase inhibition. The control of PRKs by PDK1 thus evidences a novel strategy of substrate-directed control involving GTPases.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10753910     DOI: 10.1074/jbc.275.15.11064

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  41 in total

Review 1.  PAK and other Rho-associated kinases--effectors with surprisingly diverse mechanisms of regulation.

Authors:  Zhou-shen Zhao; Ed Manser
Journal:  Biochem J       Date:  2005-03-01       Impact factor: 3.857

2.  Hypotonic swelling-induced activation of PKN1 mediates cell survival in cardiac myocytes.

Authors:  Katsuya Kajimoto; Dan Shao; Hiromitsu Takagi; Gregorio Maceri; Daniela Zablocki; Hideyuki Mukai; Yoshitaka Ono; Junichi Sadoshima
Journal:  Am J Physiol Heart Circ Physiol       Date:  2010-10-29       Impact factor: 4.733

3.  Lsc activity is controlled by oligomerization and regulates integrin adhesion.

Authors:  Jiancheng Hu; Pamela Strauch; Anatoly Rubtsov; Erin E Donovan; Roberta Pelanda; Raul M Torres
Journal:  Mol Immunol       Date:  2007-12-21       Impact factor: 4.407

4.  Structure of an SspH1-PKN1 complex reveals the basis for host substrate recognition and mechanism of activation for a bacterial E3 ubiquitin ligase.

Authors:  Alexander F A Keszei; Xiaojing Tang; Craig McCormick; Elton Zeqiraj; John R Rohde; Mike Tyers; Frank Sicheri
Journal:  Mol Cell Biol       Date:  2013-11-18       Impact factor: 4.272

Review 5.  The nuts and bolts of AGC protein kinases.

Authors:  Laura R Pearce; David Komander; Dario R Alessi
Journal:  Nat Rev Mol Cell Biol       Date:  2010-01       Impact factor: 94.444

6.  The interaction of PKN3 with RhoC promotes malignant growth.

Authors:  Keziban Unsal-Kacmaz; Shoba Ragunathan; Edward Rosfjord; Stephen Dann; Erik Upeslacis; Mary Grillo; Richard Hernandez; Fiona Mack; Anke Klippel
Journal:  Mol Oncol       Date:  2011-12-28       Impact factor: 6.603

Review 7.  The atypical PKCs in inflammation: NF-κB and beyond.

Authors:  Maria T Diaz-Meco; Jorge Moscat
Journal:  Immunol Rev       Date:  2012-03       Impact factor: 12.988

8.  Erufosine increases RhoB expression in oral squamous carcinoma cells independent of its tumor suppressive mode of action - a short report.

Authors:  Shariq S Ansari; Nurullah Akgün; Martin R Berger
Journal:  Cell Oncol (Dordr)       Date:  2016-11-03       Impact factor: 6.730

9.  Protein kinase N2 regulates AMP kinase signaling and insulin responsiveness of glucose metabolism in skeletal muscle.

Authors:  Maxwell A Ruby; Isabelle Riedl; Julie Massart; Marcus Åhlin; Juleen R Zierath
Journal:  Am J Physiol Endocrinol Metab       Date:  2017-07-18       Impact factor: 4.310

10.  RhoB regulates PDGFR-beta trafficking and signaling in vascular smooth muscle cells.

Authors:  Minzhou Huang; James B Duhadaway; George C Prendergast; Lisa D Laury-Kleintop
Journal:  Arterioscler Thromb Vasc Biol       Date:  2007-10-19       Impact factor: 8.311

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.